CRISPR and Gene Editing Approaches in Prostate Cancer: Clinical Applications and Therapeutic Potential.
CRISPR gene editing shows promise in prostate cancer research, with clinical trials beginning despite remaining regulatory and delivery challenges.
This systematic narrative review covers CRISPR gene-editing approaches in prostate cancer spanning target identification, preclinical models, and emerging clinical translation. It highlights the convergence of CRISPR with immunotherapy platforms and precision oncology, identifying the regulatory and delivery hurdles that remain before broad clinical adoption.
What the study was
- Study design
- Narrative review
- Population
- Prostate cancer patients (review context)
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Critical Reviews in Oncology/Hematology
Why it surfaced
Comprehensive review of CRISPR in prostate cancer covering clinical translation stage; relevant to precision oncology and novel therapeutics watchlist topics; timely given emerging first-in-human CRISPR trials.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.